Unlike MMRV (which carries a small, well-documented increase in febrile-seizure risk for the 1st dose), there’s no new safety signal to justify changing hepatitis B policy. Today’s ACIP briefs show hep B birth-dose safety and highlight risks of rescinding it. The birth dose reduces failure points in real-world care and serves as a safety net when screening or documentation is missed.
We know what happens without the birth dose:
- Maternal screening misses cases
- Babies get infected from household contacts
- ~90% of infected infants develop chronic infection leading to lifelong liver disease, cancer, and premature death
Before universal infant vaccination, thousands of U.S. infants and young children were infected each year despite targeted strategies.
The graph shows 30 years of uninterrupted success.
Tomorrow they vote to reverse it.
For what — to appease “public concerns”? To score political points?
This is how diseases return: by undoing proven prevention without scientific cause.
Watch tomorrow’s vote closely. This is bigger than one vaccine — it’s about whether evidence or ideology drives U.S. health policy.